Korean drug manufacturers’ dependence on co-marketing tops 20% in revenue

The domestic firms’ dependence on the co-promotion of other companies’ original brands reached 20 percent in earnings last year, according to Yakup Shinmoon.

The trade paper said that 106 Korean companies achieved 74 percent of revenue by selling their own products, while depending on other sales to co-marketing with multinational companies.

The co-marketing dependency for Jeil Pharmaceu...